Related references
Note: Only part of the references are listed.Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a Rapid and Accessible Tool That Exploits Genomic Data in Public Health and Clinical Microbiology Applications
Charlene M. C. Rodrigues et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2021)
Effectiveness of Meningococcal Vaccines at Reducing Invasive Meningococcal Disease and Pharyngeal Neisseria meningitidis Carriage: A Systematic Review and Meta-analysis
Mark McMillan et al.
CLINICAL INFECTIOUS DISEASES (2021)
Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1-4 cross-sectional survey results
Jenny M. MacLennan et al.
LANCET INFECTIOUS DISEASES (2021)
Cross-reactivity of 4CMenB vaccine-induced antibodies against meningococci belonging to non-B serogroups in Italy
Cecilia Fazio et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2021)
Meningococcal B Vaccine and Meningococcal Carriage in Adolescents in Australia
Helen S. Marshall et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Herd Protection against Meningococcal Disease through Vaccination
Stephen A. Clark et al.
MICROORGANISMS (2020)
Multicomponent meningococcal serogroup B vaccination elicits cross-reactive immunity in infants against genetically diverse serogroup C, W and Y invasive disease isolates
Alessia Biolchi et al.
VACCINE (2020)
Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors
S. Watle et al.
EPIDEMIOLOGY AND INFECTION (2020)
B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis
Helen S. Marshall et al.
BMJ OPEN (2019)
Invasive Meningococcal Disease due to Nongroupable Neisseria meningitidis-Active Bacterial Core Surveillance Sites, 2011-2016
Lucy A. McNamara et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
B Part of It study: a longitudinal study to assess carriage of Neisseria meningitidis in first year university students in South Australia
Mark McMillan et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2019)
Induction of salivary antibody levels in Dutch adolescents after immunization with monovalent meningococcal serogroup C or quadrivalent meningococcal serogroup A, C, Wand Y conjugate vaccine
Mariette B. van Ravenhorst et al.
PLOS ONE (2018)
Meningococcal carriage among a university student population - United States, 2015
Lucy Breakwell et al.
VACCINE (2018)
The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection
Ray Borrow et al.
EXPERT REVIEW OF VACCINES (2017)
Meningococcal Carriage Following a Vaccination Campaign With MenB-4C and MenB-FHbp in Response to a University Serogroup B Meningococcal Disease Outbreak-Oregon, 2015-2016
Lucy A. McNamara et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Differences in the population structure of Neisseria meningitidis in two Australian states: Victoria and Western Australia
Shakeel Mowlaboccus et al.
PLOS ONE (2017)
Effect of Vaccine-Elicited Antibodies on Colonization of Neisseria meningitidis Serogroup B and C Strains in a Human Bronchial Epithelial Cell Culture Model
Vianca Vianzon et al.
CLINICAL AND VACCINE IMMUNOLOGY (2017)
Meningococcal carriage in Dutch adolescents and young adults; a cross-sectional and longitudinal cohort study
M. B. van Ravenhorst et al.
CLINICAL MICROBIOLOGY AND INFECTION (2017)
Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016
Heidi M. Soeters et al.
CLINICAL INFECTIOUS DISEASES (2017)
Temporal Changes in BEXSERO® Antigen Sequence Type Associated with Genetic Lineages of Neisseria meningitidis over a 15-Year Period in Western Australia
Shakeel Mowlaboccus et al.
PLOS ONE (2016)
Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
Shamez N. Ladhani et al.
EMERGING INFECTIOUS DISEASES (2016)
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial
Robert C. Read et al.
LANCET (2014)
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? (Publication with Expression of Concern. See vol. 38, pg. 5577, 2020)
Eva Hong et al.
VACCINE (2013)
BIGSdb: Scalable analysis of bacterial genome variation at the population level
Keith A. Jolley et al.
BMC BIOINFORMATICS (2010)
Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria
Q Zhang et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination
MCJ Maiden et al.
LANCET (2002)
Risk factors for carriage of Neisseria meningitidis during an outbreak in Wales
PE Fitzpatrick et al.
EMERGING INFECTIOUS DISEASES (2000)
Lack of immunity in university students before an outbreak of serogroup C meningococcal infection
GR Jones et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Share Paper
